Myristic Acid
CAS 544-63-8
Myristic Acid (CAS 544-63-8) is a pharmaceutical compound with 8 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 34565.64 nM | 24 | - |
| - | IC50 | 32959.329090909094 nM | 10 | - |
| - | EC50 | 11452.5 nM | 4 | - |
| - | MIC | 4039343.72 nM | 3 | - |
| - | MIC | 250 ug.mL-1 | 2 | - |
| - | IC50 | 2 10^2 uM | 1 | - |
| - | IC50 | 1 10^3 uM | 1 | - |
| - | Ki | 2640 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| FFA1 receptor FFAR1 |
Full agonist | 4.5 pEC50 | 12496284|12565875|12629551 |
| FFA4 receptor FFAR4 |
Full agonist | 5.199999809265137 pEC50 | 22282525 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| MYRISTIC ACID | 1356758 | SU | MTHSPL |
| myristic acid | 1356758 | SU | MTHSPL |
| myristic acid | 1356758 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Myristic Acid used for in pharmaceutical contexts?
Myristic Acid (CAS 544-63-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Myristic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Myristic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Myristic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Morus Alba Root Extract with EU status "permitted".
What clinical phase is Myristic Acid in?
No phase 1-4 clinical development badge is rendered for Myristic Acid because the matched compound identifier rows do not contain a max-phase value.